or
Sun Pharmaceutical Industries’ big purchase of US-based Organon is the kind of overseas acquisition that several other Indian groups have pursued in the past. Founder Dilip Shanghvi has made what is clearly the biggest transaction in his...
AAS YOU DRIVE from Ahmedabad towards Gandhinagar, you see a shiny new city rising along the banks of the Sabarmati river. The region, once dotted by green fields, is rapidly emerging as a gateway for global capital as new multi-storey towers...
IIn the verdant surroundings of central Mumbai’s Vikhroli, Pirojsha Godrej is in a relaxed mood. The vast campus is synonymous with Godrej and houses multiple group businesses. In many ways, the rich legacy of the group, founded by...
For years, India’s capital markets moved in step with foreign portfolio investors (FPIs). Their lows alone were enough to set the tone. But early 2026 hinted at a quiet shift. Domestic mutual funds, powered by millions of Indians backing their...